Tosk, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690 (NCT05658016) | Tosk, Inc. | 2022-06-17 |
| Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690 (NCT05669521) | Tosk, Inc. | 2022-06-15 |
| Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690 (NCT04046250) | Tosk, Inc. | 2019-05-15 |
Track Tosk, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.